Position in PFE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,537,466
-$43,259 QoQ
Shares Held
446,491
-11.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 38.56942245196432.ToString("F0")%
Shared 0.ToString("F0")%
None 61.43057754803568.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2026CallValue
$28
CallShares
1
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Orion Porfolio Solutions, LLC holds $221,310,249 across 15 Drug Manufacturers - General names. PFE ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
226,615 | $55,393,769 | |
| 2 | LLY |
ELI LILLY & Co
|
51,627 | $47,484,964 | |
| 3 | ABBV |
AbbVie Inc.
|
138,202 | $30,057,552 | |
| 4 | AZN |
Astrazeneca PLC
|
80,263 | $15,829,467 | |
| 5 | MRK |
Merck & Co., Inc.
|
124,118 | $14,930,153 | |
| 6 | PFE |
Pfizer Inc
This page
|
446,491 | $12,537,466 | |
| 7 | AMGN |
Amgen Inc
|
27,190 | $9,566,800 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
68,638 | $9,566,077 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,537,466 | 446,491 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $28 | 1 | Call | Sole | 2026-05-13 | |
| 2025-12-31 | $12,580,725 | 505,250 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,053,161 | 473,044 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $17,192,220 | 709,250 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $16,938,396 | 668,445 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $15,447,623 | 582,270 | Shares | Sole | 2025-08-01 | |
| 2024-09-30 | $15,995,658 | 552,718 | Shares | Sole | 2025-07-31 | |
| 2024-06-30 | $16,388,137 | 585,709 | Shares | Sole | 2025-07-31 | |
| 2024-03-31 | $15,500,262 | 558,568 | Shares | Sole | 2025-07-31 | |
| 2023-12-31 | $14,022,889 | 487,075 | Shares | Sole | 2025-07-31 | |
| 2023-09-30 | $19,523,331 | 588,584 | Shares | Sole | 2025-07-31 | |
| 2023-06-30 | $24,648,153 | 671,978 | Shares | Sole | 2025-07-31 | |
| 2023-03-31 | $27,130,980 | 664,975 | Shares | Sole | 2025-07-31 | |
| 2022-12-31 | $20,845,713 | 406,825 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $17,108,059 | 390,952 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $20,961,881 | 399,807 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $20,320,656 | 392,518 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,693,517 | 316,571 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $12,803,775 | 297,693 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $11,343,947 | 289,682 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $8,880,262 | 245,108 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $9,800,661 | 266,250 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,306,613 | 410,877 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $1,162,278 | 37,463 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $396,417 | 12,801 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||